Lifecore Biomedical to Participate in Upcoming Investor Conferences GlobeNewswire September 02, 2025 CHASKA, Minn., Sept. 02, 2025 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in multiple upcoming investor conferences. Details regarding Lifecore's participation are as follows: Morgan […]

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made grants of options to purchase an aggregate of 29,700of the Company's common shares to two new employees on September 2, 2025 (each, a “Grant”). https://mma.prnewswire.com/media/2543351/ADC_Therapeutics_SA__logo.jpg The Grants were offered

Xulon Press presents a fictional work that can still hit close to home. AuthorJody B. Smith shares a story about the consequences of drug use inCrossroad($13.49, paperback, 9798868522376) https://mma.prnewswire.com/media/2761188/Xulon_Press_CROSSROAD_book_cover.jpg A teenager runs away from home and finds herself in a much darker place, trapped in the sex trade and addicted to drugs. After she is

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 466 restricted stock units (RSUs) to two newly-hired employees. These RSU awards were granted as of August 31, 2025 (the “Grant Date”) pursuant to the Company's 2022 Inducement Stock Incentive Plan, as amended,

Strengthens North America Platform and Positions for Further Growth Radiant Logistics, Inc. (NYSE American:RLGT), a leading provider of technology-enabled global transportation and value added logistics solutions, today announced it has acquired an 80% ownership interest in Weport, S.A. de C.V. (“Weport”), a Mexico-based, privately held company that provides a full range of global transportation and

EastGroup Properties, Inc. (NYSE: EGP)(the “Company”, “we”, “our”, “us” or “EastGroup”) announced today its participation in upcoming conferences. https://mma.prnewswire.com/media/2045746/EastGroup_Properties_v4_Logo.jpg Commenting on the Company's activity, Marshall Loeb, CEO, stated, “Our quarter-to-date performance is tracking in line with our expectations, with the operating portfolio 96.9% leased and 95.9% occupied. We've been pleased to see the pickup in

Calamos Investments®* has announced monthly distributions and sources of distributions paid in September 2025 to shareholders of its seven closed-end funds (the Funds) pursuant to the Funds' respective distribution plans. Fund Distribution Payable date Record date Ex-dividend dateCHI (inception 06/26/2002)Calamos Convertible Opportunities and Income Fund $0.0950 9/22/25 9/15/25 9/15/25CHY (inception 05/28/2003)Calamos Convertible and High Income

Greif Completes Sale of Containerboard Business GlobeNewswire September 02, 2025 DELAWARE, Ohio, Sept. 02, 2025 (GLOBE NEWSWIRE) — Greif, Inc. (NYSE: GEF, GEF.B), a global leader in performance packaging and services, announced today it has completed the previously announced sale of its containerboard business to Packaging Corporation of America. “The closing of this sale marks

Diginex Announces move into Digital Asset Sustainability Project Verification; Signs Strategic Alliance with BlockRidge GlobeNewswire September 02, 2025 LONDON, Sept. 02, 2025 (GLOBE NEWSWIRE) — Diginex Limited (NASDAQ: DGNX) (“Diginex”), a leading provider of Sustainability RegTech solutions, and Valuit Technology Delaware LLC (hereinafter referred to as “BlockRidge”), a leading provider of tokenization and digital asset

Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire September 02, 2025 NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the recent grants of inducement non-qualified stock